Market Tracker

06/28 4:35pm ET

Nektar Therapeutics (NASDAQ:NKTR)

13.76
Delayed Data
As of 4:00pm ET
 +0.37 / +2.76%
Today’s Change
9.16
Today|||52-Week Range
17.55
-18.34%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close13.39
Today’s open13.58
Day’s range13.54 - 13.93
Volume1,052,434
Average volume (3 months)1,115,852
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-56.21%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book281.78

Competitors

 Today’s
change
Today’s
% change
EXELExelixis Inc+0.33+4.43%
INCRINC Research Holding...+0.84+2.27%
ABCOAdvisory Board Co-0.13-0.39%
DBVTDBV Technologies SA+2.83+10.00%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts